[NMusers] REGISTRATION OPEN for Annual Spring 3-day NONMEM/PDxPoP Workshop & 1st Time Modeling Delays in PK/PD Workshop - Howard County, Maryland - April 9-12, 2019

[Wilhelm-Lear, Lisa]

Registration is open for the above noted workshops!  Seating is limited - only 
20 participants allowed for each day.

Don't miss out on this opportunity to meet with Drs. Bauer, Sadler and Das, 
hands on examples using our software and the chance to speak with them about 
any issues you may have concerning NONMEM and PDxPoP.

Additionally, the Modeling Delays in PK/PD workshop will be presented for the 
first time by Wojciech Krzyzanski, Ph.D, Gilbert Koch, Ph.D, and Robert Bauer, 
Ph.D - Please do not miss out on an opportunity such as this.

For more information and to register, please contact me directly at the email 
below.

Kind regards,


Lisa R. Wilhelm-Lear
Customer Service Lead
NONMEM / PDxPoP Software

Phone:  301-944-6771
Fax: 215-789-9549
lisa.wilh...@iconplc.com
www.iconplc.com

ICON plc made the following annotations.
--
This e-mail transmission may contain confidential or legally privileged 
information that is intended only for the individual or entity named in the 
e-mail address. If you
are not the intended recipient, you are hereby notified that any disclosure, 
copying, distribution, or reliance upon the contents of this e-mail is strictly 
prohibited. If
you have received this e-mail transmission in error, please reply to the 
sender, so that ICON plc can arrange for proper delivery, and then please 
delete the message.

Thank You,

ICON plc
South County Business Park
Leopardstown
Dublin 18
Ireland
Registered number: 145835

[NMusers] Pharmacometrics Webinar with Stephan Schmidt, March 14th

[Rebecca Baillie]

Pharmacometrics, PBPK, QSP - What's Next?

Stephan Schmidt, B.Pharm, Ph.D., F.C.P.
Center for Pharmacometrics & Systems Pharmacology, University of Florida

 Thursday, March 14, 2019, 12:00 to 1:00 pm EDT 

Register at https://www.rosaandco.com/webinars

Abstract: 
Modeling & simulation (M) tools have long been used in engineering and 
aerospace industries to develop products that would be prohibitively expensive 
to optimize through iterative improvement of prototypes. Modern drug 
development is now adapting and integrating analogous tools based on 
information from all phases of the development process since it is neither 
cost-effective nor time-efficient to tackle all open questions experimentally. 
As a result, an increasing number of decisions are now based on M at various 
levels of physiological and temporal complexity. However, prospective 
identification of clinically relevant sources of variability remain a 
challenge. To overcome this challenge the integrated use of multidisciplinary 
research approaches is needed.

The objective of this webinar is to provide selected case examples that 
highlight the added value of integrated use of real-world outcomes-, 
pharmacometric, and physiologically based pharmacokinetic approaches for 
identifying clinically-relevant sources of variability and translating them 
into actionable items.